CLOV RSI Chart
Last 7 days
9.8%
Last 30 days
45.2%
Last 90 days
-9.1%
Trailing 12 Months
-15.1%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 1.9B | 0 | 0 | 0 |
2023 | 3.1B | 2.8B | 2.4B | 2.0B |
2022 | 2.1B | 2.6B | 3.0B | 3.5B |
2021 | 707.7M | 948.1M | 1.2B | 1.5B |
2020 | 514.9M | 567.6M | 620.2M | 672.9M |
2019 | 0 | 0 | 0 | 462.3M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
May 08, 2024 | toy andrew | sold (taxes) | -74,269 | 0.87 | -85,367 | chief executive officer |
Apr 18, 2024 | priest brady patrick | sold (taxes) | -20,422 | 0.63 | -32,416 | ceo of home care |
Apr 03, 2024 | reynoso jamie l. | sold (taxes) | -4,094 | 0.76 | -5,387 | ceo, medicare advantage |
Apr 01, 2024 | toy andrew | sold (taxes) | -237,423 | 0.77 | -308,341 | chief executive officer |
Mar 15, 2024 | soares karen | sold (taxes) | -4,134 | 0.8 | -5,168 | general counsel & secretary |
Mar 15, 2024 | reynoso jamie l. | sold (taxes) | -4,302 | 0.8 | -5,378 | ceo, medicare advantage |
Mar 14, 2024 | reynoso jamie l. | sold (taxes) | -5,677 | 0.73 | -7,777 | ceo, medicare advantage |
Mar 14, 2024 | wai conrad | sold (taxes) | -54,309 | 0.73 | -74,396 | chief technology officer |
Mar 14, 2024 | loengard anna u | bought | 100,010 | 0.73 | 137,000 | - |
Mar 14, 2024 | loengard anna u | bought | 9,946 | 0.73 | 13,625 | - |
Which funds bought or sold CLOV recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | JANE STREET GROUP, LLC | reduced | -50.7 | -703,813 | 491,413 | -% |
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | added | 1.73 | -48,447 | 271,011 | -% |
May 16, 2024 | Jaffetilchin Investment Partners, LLC | added | 30.24 | 3,132 | 39,494 | -% |
May 15, 2024 | TWO SIGMA INVESTMENTS, LP | reduced | -30.43 | -1,451,040 | 2,005,560 | -% |
May 15, 2024 | MORGAN STANLEY | reduced | -3.7 | -152,747 | 622,871 | -% |
May 15, 2024 | GOLDMAN SACHS GROUP INC | added | 116 | 422,860 | 950,284 | -% |
May 15, 2024 | CITADEL ADVISORS LLC | reduced | -74.81 | -100,718 | 26,791 | -% |
May 15, 2024 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | new | - | 3,629 | 3,629 | -% |
May 15, 2024 | WEDBUSH SECURITIES INC | sold off | -100 | -10,000 | - | -% |
May 15, 2024 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | added | 187 | 132 | 227 | -% |
Unveiling Clover Health Investments, Corp.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Date Filed | Form Type | Document | |
---|---|---|---|
Peers (Alternatives to Clover Health Investments, Corp.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 482.9B | 379.5B | 31.44 | 1.27 | ||||
CI | 96.2B | 206.0B | 24.97 | 0.47 | ||||
HCA | 84.6B | 66.7B | 15.46 | 1.27 | ||||
CVS | 72.4B | 360.9B | 9.89 | 0.2 | ||||
CNC | 41.7B | 155.5B | 15.24 | 0.27 | ||||
DVA | 12.3B | 12.3B | 15.03 | 0.99 | ||||
UHS | 11.9B | 14.7B | 14.63 | 0.81 | ||||
MID-CAP | ||||||||
CHE | 8.5B | 2.3B | 30.15 | 3.73 | ||||
ACHC | 6.2B | 3.0B | -545.12 | 2.06 | ||||
AMEH | 2.3B | 1.5B | 36.62 | 1.57 | ||||
AMN | 2.2B | 3.5B | 15.49 | 0.64 | ||||
SMALL-CAP | ||||||||
ADUS | 1.8B | 1.1B | 27.59 | 1.67 | ||||
BKD | 1.3B | 3.0B | -7.66 | 0.44 | ||||
BEAT | 54.5M | - | -3.61 | - | ||||
AMS | 22.0M | 21.6M | 39.79 | 1.02 |
Clover Health Investments, Corp. News
Income Statement (Quarterly) | |||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 |
Revenue | -32.0% | 346,922 | 510,251 | 482,066 | 513,628 | 527,775 | 898,791 | 856,817 | 846,700 | 874,379 | 432,036 | 427,163 | 412,472 | 200,325 | 166,233 | 169,069 | 172,081 | 165,505 | - |
Gross Profit | 31.3% | 81,760 | 62,266 | 63,107 | 76,674 | 55,285 | 5,146 | 17,018 | -12,086 | 12,657 | - | -9,162 | -46,031 | - | - | - | - | - | - |
Operating Expenses | -35.8% | 369,625 | 575,911 | 523,535 | 542,435 | 600,381 | 1,006,134 | 930,913 | 949,427 | 961,860 | 618,825 | 576,416 | 594,334 | 319,413 | 233,862 | 190,687 | 148,911 | 192,135 | - |
S&GA Expenses | -100.0% | - | 45,080 | 41,747 | 42,433 | 59,215 | 55,348 | 47,832 | 47,040 | 57,697 | 55,177 | 45,846 | 45,646 | 38,618 | 41,032 | 29,847 | 21,468 | 28,483 | - |
Interest Expenses | - | - | - | - | 7.00 | - | 136 | 404 | 390 | 403 | 403 | 404 | 1,211 | 1,175 | 10,430 | 9,268 | 8,477 | 7,815 | - |
Net Income | 72.8% | -19,170 | -70,472 | -41,469 | -28,814 | -72,606 | -84,226 | -75,489 | -104,362 | -75,490 | -187,201 | -34,527 | -317,611 | -48,417 | -126,391 | 12,758 | 5,403 | -28,162 | -17.63 |
Net Income Margin | 17.7% | -0.09* | -0.10* | -0.09* | -0.09* | -0.11* | -0.10* | -0.15* | -0.16* | -0.29* | -0.40* | -0.44* | -0.51* | -0.22* | -0.20* | -0.02* | -0.64* | -0.71* | -0.79* |
Free Cashflow | 111.1% | 25,490 | -229,031 | -19,024 | 52,819 | 78,781 | -295,667 | 101,396 | -39,344 | -57,200 | -80,414 | -45,321 | -64,346 | -92,968 | -59,967 | -34,817 | 13,011 | -37,418 | - |
Balance Sheet | |||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 |
Assets | 17.7% | 672 | 571 | 1,060 | 1,258 | 1,454 | 809 | 1,558 | 2,063 | 2,680 | 951 | 952 | 1,216 | 867 | 267 | 829 | 829 | 583 | 337 |
Current Assets | 29.2% | 553 | 428 | 916 | 1,129 | 1,274 | 625 | 1,460 | 1,861 | 2,491 | 753 | 559 | 718 | 809 | 190 | 1.00 | 1.00 | - | 253 |
Cash Equivalents | 69.5% | 208 | 123 | 299 | 310 | 191 | 104 | 383 | 324 | 274 | 300 | 202 | 486 | 405 | 92.00 | 90.00 | 107 | 112 | 68.00 |
Net PPE | 2.5% | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 6.00 | 3.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | - | - | - | 2.00 |
Goodwill | - | - | - | - | - | - | 12.00 | - | - | - | 1.00 | - | - | - | 1.00 | - | - | - | 1.00 |
Liabilities | 33.4% | 379 | 284 | 738 | 927 | 1,130 | 452 | 1,166 | 1,636 | 2,190 | 411 | 540 | 901 | 278 | 433 | 31.00 | 29.00 | - | 378 |
Current Liabilities | 36.5% | 356 | 261 | 719 | 908 | 1,110 | 432 | 1,128 | 1,599 | 2,152 | 372 | 230 | 196 | 173 | 164 | 2.00 | 0.00 | 1.00 | 142 |
Long Term Debt | - | - | - | - | - | - | - | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 | 5.00 | 106 | - | - | - | 58.00 |
LT Debt, Non Current | - | - | - | - | - | - | - | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 | 24.00 | 106 | - | - | - | 58.00 |
Shareholder's Equity | 2.1% | 292 | 286 | 322 | 331 | 323 | 357 | 392 | 427 | 490 | 540 | 412 | 315 | 589 | 5.00 | 5.00 | 5.00 | 0.00 | - |
Retained Earnings | -0.9% | -2,178 | -2,159 | -2,089 | -2,047 | -2,019 | -1,946 | -1,871 | -1,796 | -1,692 | 1,616 | -1,429 | -1,395 | -1,077 | -1,028 | -2.37 | -0.07 | -0.02 | -891 |
Additional Paid-In Capital | 1.2% | 2,490 | 2,461 | 2,428 | 2,395 | 2,359 | 2,319 | 2,281 | 2,238 | 2,195 | 2,154 | 1,839 | 1,706 | 1,663 | 412 | 7.00 | 5.00 | 0.00 | 403 |
Shares Outstanding | 0.9% | 486 | 482 | 481 | - | 479 | 476 | 476 | 475 | 473 | 413 | 410 | 408 | 376 | 89.00 | 89.00 | 89.00 | 88.00 | 88.00 |
Minority Interest | - | - | - | - | - | - | - | - | - | - | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | - | - | - | - |
Float | - | - | - | - | 360 | - | - | - | 839 | - | - | - | 5,469 | - | - | - | 926 | - | - |
Cashflow (Quarterly) | |||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 |
Cashflow From Operations | 111.3% | 25,935 | -229,295 | -18,781 | 53,173 | 79,032 | -291,790 | 101,655 | -39,171 | -57,042 | -80,176 | -45,126 | -64,155 | -92,869 | -59,904 | -34,650 | 13,232 | -37,176 | -17.63 |
Share Based Compensation | -13.1% | 28,798 | 33,136 | 33,070 | 36,108 | 38,617 | 39,094 | 42,644 | 41,927 | 40,640 | 31,181 | 46,803 | 43,026 | 42,713 | 2,129 | 1,501 | 1,471 | 1,977 | - |
Cashflow From Investing | -89.0% | 9,185 | 83,662 | -20,321 | 66,491 | 10,181 | 12,656 | -43,389 | 89,353 | 36,513 | -106,491 | -242,345 | 170,865 | -257,476 | 67,557 | 1,500 | -14,163 | 82,510 | - |
Cashflow From Financing | 88.7% | -3,359 | -29,617 | -1,963 | -147 | -2,134 | 82,478 | 132 | 458 | -5,608 | 284,371 | 3,988 | -25,470 | 662,504 | -5,037 | 15,470 | -4,151 | -438 | 18.00 |
Buy Backs | 306.2% | 3,359 | 827 | 1,994 | 417 | 2,982 | 42.00 | 276 | 105 | 5,939 | - | 147 | - | - | - | - | - | - | - |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenues: | ||
Premiums earned, net (Net of ceded premiums of $101 and $122 for the three months ended March 31, 2024 and 2023, respectively) | $ 341,722 | $ 317,086 |
Other income | 5,200 | 4,906 |
Total revenues | 346,922 | 321,992 |
Operating expenses: | ||
Net medical claims incurred | 265,162 | 274,789 |
Salaries and benefits | 59,223 | 68,981 |
General and administrative expenses | 44,569 | 57,644 |
Premium deficiency reserve benefit | 0 | (1,810) |
Depreciation and amortization | 318 | 279 |
Restructuring costs | 353 | 1,807 |
Total operating expenses | 369,625 | 401,690 |
Loss from continuing operations | (22,703) | (79,698) |
Loss on investment | 467 | 0 |
Net loss from continuing operations | (23,170) | (79,698) |
Net income from discontinued operations (Note 17) | 4,000 | 7,092 |
Net loss | $ (19,170) | $ (72,606) |
Continuing Operations: | ||
Basic weighted average number of Class A and Class B common shares and common share equivalents outstanding (in shares) | 486,374,644 | 478,805,067 |
Diluted weighted average number of Class A and Class B common shares and common share equivalents outstanding (in shares) | 486,374,644 | 478,805,067 |
Basic net loss per share (in dollars per share) | $ (0.05) | $ (0.17) |
Diluted net loss per share (in dollars per share) | $ (0.05) | $ (0.17) |
Discontinued operations: | ||
Basic weighted average number of Class A and Class B common shares and common share equivalents outstanding (in shares) | 486,374,644 | 478,805,067 |
Diluted weighted average number of Class A and Class B common shares and common share equivalents outstanding (in shares) | 567,451,166 | 566,629,082 |
Basic earnings per share (in dollars per share) | $ 0.01 | $ 0.01 |
Diluted earnings per share (in dollars per share) | $ 0.01 | $ 0.01 |
Net unrealized (loss) gain on available-for-sale investments | $ (190) | $ 2,343 |
Comprehensive loss | $ (19,360) | $ (70,263) |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 208,255 | $ 116,407 |
Short-term investments | 9,120 | 12,218 |
Investment securities, available-for-sale (Amortized cost: 2024: $119,528; 2023: $101,412) | 118,056 | 100,702 |
Investment securities, held-to-maturity (Fair value: 2024: $6,853; 2023: $6,778) | 6,923 | 6,902 |
Accrued retrospective premiums | 70,607 | 22,076 |
Other receivables | 22,533 | 16,666 |
Healthcare receivables | 83,867 | 64,164 |
Surety bonds and deposits | 740 | 542 |
Prepaid expenses | 16,761 | 14,418 |
Other assets, current | 4,949 | 1,404 |
Assets related to discontinued operations (Note 17) | 10,926 | 72,471 |
Total current assets | 552,737 | 427,970 |
Investment securities, available-for-sale (Amortized cost: 2024: $98,221; 2023: $121,868) | 97,133 | 120,208 |
Investment securities, held-to-maturity (Fair value: 2024: $693; 2023: $692) | 792 | 793 |
Property and equipment, net | 5,209 | 5,082 |
Operating lease right-of-use assets | 3,124 | 3,382 |
Other intangible assets | 2,990 | 2,990 |
Other assets, non-current | 9,785 | 10,246 |
Total assets | 671,770 | 570,671 |
Current liabilities | ||
Unpaid claims | 238,602 | 135,737 |
Accounts payable and accrued expenses | 35,408 | 37,184 |
Accrued salaries and benefits | 28,327 | 20,951 |
Deferred revenue | 0 | 3,099 |
Operating lease liabilities | 1,623 | 1,665 |
Liabilities related to discontinued operations (Note 17) | 50,622 | 60,099 |
Total current liabilities | 356,389 | 261,115 |
Long-term operating lease liabilities | 2,717 | 2,998 |
Other liabilities, non-current | 20,190 | 20,164 |
Total liabilities | 379,296 | 284,277 |
Commitments and Contingencies (Note 13) | ||
Stockholders' equity | ||
Additional paid-in capital | 2,490,036 | 2,461,238 |
Accumulated other comprehensive loss | (2,560) | (2,370) |
Accumulated deficit | (2,178,964) | (2,159,794) |
Less: Treasury stock, at cost; 11,613,745 and 7,912,750 shares held at March 31, 2024 and December 31, 2023, respectively | (16,088) | (12,729) |
Total stockholders' equity | 292,474 | 286,394 |
Total liabilities and stockholders' equity | 671,770 | 570,671 |
Common Class A | ||
Stockholders' equity | ||
Common stock, value | 41 | 40 |
Common Class B | ||
Stockholders' equity | ||
Common stock, value | 9 | 9 |
Related party | ||
Current liabilities | ||
Due to related parties, net | 881 | 1,363 |
Other liabilities, current | 881 | 1,363 |
Nonrelated party | ||
Current liabilities | ||
Due to related parties, net | 926 | 1,017 |
Other liabilities, current | $ 926 | $ 1,017 |